Sunday, August 3, 2025
SFDA Approves Registration Of Skyclarys For Treating Friedreich’s Ataxia In Adults And Adolescents
By OneArabia, Wednesday, July 23, 2025. The Saudi Food and Drug Authority (SFDA) has given the green light for Skyclarys (Omaveloxolone), a drug previously recognised as an orphan drug under their Orphan Drug Program. This medication is designed to treat Friedreich’s ataxia in individuals aged 16 and older.
